Mankind Pharma has reported result for first quarter ended June 30, 2025 (Q1FY26).
The company has reported 18.37% fall in its net profit at Rs 412.76 crore for the quarter ended June 30, 2025 as compared to Rs 505.66 crore for the same quarter in the previous year. However, the total income of the company increased by 3.86% at Rs 2605.58 crore for Q1FY26 as compared to Rs 2508.66 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 18.30% fall in its net profit at Rs 438.32 crore for Q1FY26 as compared to Rs 536.49 crore for the same quarter in the previous year. However, the total income of the company increased by 23.02% at Rs 3650.23 crore for Q1FY26 as compared to Rs 2967.25 crore for the corresponding quarter previous year.
